Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medication

Background The neurobiology of psychotic depression is not well understood and can be confounded by antipsychotics. Magnetic resonance spectroscopy (MRS) is an ideal tool to measure brain metabolites non-invasively. We cross-sectionally assessed brain metabolites in patients with remitted psychotic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Brain imaging and behavior 2024-02, Vol.18 (1), p.117-129
Hauptverfasser:	Tani, Hideaki, Moxon-Emre, Iska, Forde, Natalie J., Neufeld, Nicholas H., Bingham, Kathleen S., Whyte, Ellen M., Meyers, Barnett S., Alexopoulos, George S., Hoptman, Matthew J., Rothschild, Anthony J., Uchida, Hiroyuki, Flint, Alastair J., Mulsant, Benoit H., Voineskos, Aristotle N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - therapeutic use Antipsychotics Aspartic Acid Biomedical and Life Sciences Biomedicine Brain Brain - diagnostic imaging Brain - metabolism Choline Choline - metabolism Cortex (cingulate) Creatine Creatine - metabolism Depression Glutamine Glutamine - metabolism Humans Inositol Inositol - metabolism Inositols Magnetic Resonance Imaging Magnetic resonance spectroscopy Mental depression Metabolites N-Acetylaspartate Neuropsychology Neuroradiology Neurosciences Olanzapine Olanzapine - metabolism Olanzapine - therapeutic use Placebos Prefrontal cortex Psychiatry Psychosis Psychotic depression Remission Sertraline Sertraline - metabolism Spectrum analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!